Comparative Analysis of Radiofrequency Ablation and Microwave Ablation Procedures for the Treatment of Small Saphenous Varicose Veins
Condition(s) studied
Investigational drug(s) / intervention(s)
Radiofrequency ablation and microwave ablation are used to treat small saphenous varicose veins, respectively: During the procedure, 2% lidocaine was injected subcutaneously along the course of the saphenous vein under ultrasound guidance, and after local anaesthesia, an incision was made at the ankle joint of the saphenous vein to locate the saphenous vein, and a radiofrequency guidewire and catheter sheath were introduced.The saphenous vein was incised at the ankle joint under local anaesthesia. Under ultrasound monitoring, the radiofrequency catheter was placed in the saphenous popliteal vein at a distance of 1\~2 cm and the position of the catheter was fixed, and then anaesthesia and swelling fluid was injected into the fascial tissues around the main trunk of the small saphenous vein in segments.The two groups were treated with radiofrequency ablation and microwave ablation surgery, respectively.
Study summary
Objective: To investigate the clinical efficacy of ultrasound-guided radiofrequency ablation and microwave ablation in the treatment of primary saphenous varicose veins.
Eligibility
Primary outcome measure(s)
- 6-month postoperative occlusion rate — 6 months after surgery
occlusion defined as no flow recirculation of the closed treated segment of the vein as confirmed by Doppler ultrasound
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospital of Chengdu University of Traditional Chinese Medicine | Chengdu | China | Recruiting |
More Chengdu University of Traditional Chinese Medicine trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06711120 on ClinicalTrials.gov ↗ ← All trials in China